T1	Participants 61 70	melanoma.
T2	Participants 153 203	patients with positive sentinel lymph nodes (SLN).
T3	Participants 401 456	patients treated in a referral cancer center in Brazil.
T4	Participants 465 597	Patients with stage I/II melanoma, consecutively submitted to a SLN procedure by the same surgeon from 2000 to 2006, were evaluated.
T5	Participants 839 902	381 patients who underwent SLN biopsy, 103 (27%) were positive.
